- There is a significant difference in the ratio of severe symptoms between the RNA blood positive group (100%) and the RNA blood negative group (23,5%).
- There is a significant difference in the ratio of severe symptoms between the RNA anal swab positive group (72,7%) and the RNA blood negative group (23,5%).
- Both tests could be benefit for disease evolution predictor.
This data comes from a retrospective study including 57 patients with confirmed 2019-nCoV and pneumonia-based diseases. 6 of them were detected to be blood positive. They wanted to investigate if special profiles of virus replication were correlated with patient with severe clinical symptoms.
Source :
Chen W., Yuan X., Deng X., Li Y., Cai X., Li L., He R., et al (February 26, 2020). Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Journal Emerging Microbes & Infections. https://doi.org/10.1080/22221751.2020.1732837